TLDR Infrared light might help treat stubborn alopecia areata.
The document discussed the use of infrared irradiation as an adjuvant therapy for recalcitrant alopecia areata. The study was conducted by researchers from various departments in Taiwan, including the Department of Dermatology at Kaohsiung Veterans General Hospital and the Institute of Biophotonics at National Yang-Ming University. The findings suggested that infrared irradiation could potentially serve as a supplementary treatment for patients with alopecia areata who did not respond to conventional therapies. However, specific details about the study's methodology, sample size, and results were not provided in the summary.
48 citations
,
May 1999 in “International Journal of Dermatology”
Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.
The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.
The user suspects scarring alopecia and is exploring NSAIDs and turmeric/pepper for inflammation-related hair loss, having experienced burning and thinning with finasteride and testosterone reduction. They are seeking feedback while unable to afford a dermatologist.
In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.
Eli Lilly's drug baricitinib showed effectiveness in treating alopeciaareata, with higher doses resulting in significant hair regrowth compared to placebo. The treatment is not for male pattern baldness.
The conversation discusses the potential of new hair loss treatments, with a focus on pyrilutamide, gt20029, and topical alfatradiol, and the possibility of improving their effectiveness through methods like increased concentration and microneedling. Dutasteride is also mentioned as a stronger option.
